Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M

B C Nair1, A L DeVico, S Nakamura

  • 1Department of Cell Biology, Advanced BioScience Laboratories, Inc., Kensington, MD.

Science (New York, N.Y.)
|March 13, 1992
PubMed

Insights

Researchers found that Oncostatin M, a protein from HTLV-II infected cells, significantly boosts the growth of AIDS-associated Kaposi's sarcoma cells. This discovery offers new insights into Kaposi's sarcoma cell proliferation and potential therapeutic targets.

Area of Science:

  • Oncology
  • Virology
  • Immunology

Background:

  • Human T cell leukemia virus type 2 (HTLV-II) infection is associated with certain cancers.
  • Acquired immunodeficiency syndrome (AIDS)-associated Kaposi's sarcoma (AIDS-KS) is a significant opportunistic infection.
  • Understanding factors that promote AIDS-KS cell growth is crucial for developing treatments.

Purpose of the Study:

  • To identify factors in conditioned medium from HTLV-II infected cells that support AIDS-KS cell growth.
  • To characterize the protein responsible for promoting AIDS-KS cell proliferation.
  • To evaluate the effect of this protein on AIDS-KS cell growth.

Main Methods:

  • Culturing AIDS-KS cells in conditioned medium from HTLV-II infected T cells.
  • Purification of a growth-promoting protein from the conditioned medium.
  • Amino-terminal sequencing of the purified protein.
  • Assessing the effect of the purified protein on AIDS-KS cell growth in vitro.

Main Results:

  • Conditioned medium from HTLV-II infected T cells supported long-term culture of AIDS-KS cells.
  • A 30 kilodalton protein was purified from this medium.
  • The purified protein's amino-terminal sequence matched Oncostatin M.
  • Oncostatin M significantly increased AIDS-KS cell growth at very low concentrations (< 1 ng/mL).

Conclusions:

  • Oncostatin M is present in conditioned medium of HTLV-II infected cells.
  • Oncostatin M promotes the growth of AIDS-KS cells.
  • This finding may reveal a mechanism for Kaposi's sarcoma development in AIDS patients.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...